Deutsche Nationalbibliothek
metadata only
Susceptibility of clinical isolates, laboratory-adapted and drug-resistant herpes simplex virus strains to helicase-primase inhibitor adibelivir (IM-250) and its synergy in combination therapy with acyclovir, penciclovir and foscarnet
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1)#1124944
- The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood#862974
- ВЛИЯНИЕ АКТИВНОЙ И ЛАТЕНТНОЙ ФАЗ ИНФЕКЦИЙ, ВЫЗВАННЫХ HERPES SIMPLEX VIRUS-1,2 (HSV-1,2), НА СУБПОПУЛЯЦИОННЫЙ СОСТАВ ЛИМФОЦИТОВ ПЕРИФЕРИЧЕСКОЙ КРОВИ У ПАЦИЕНТОВ С ВОСПАЛИТЕЛЬНЫМИ ЗАБОЛЕВАНИЯМИ ПЕРЕДНЕГО ОТРЕЗКА ГЛАЗА#619355
- Helicase-primase inhibitors as next-generation anti-HSV agents: from current clinical status to structure-activity relationships and patent coverage.#631505
- The Efficacy of Systemic Valacyclovir (Valtrex) on Periodontitis#915199
Record · ID 619770
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive